By Amy Feldman, Forbes StaffSource:
Forbes InnovationIn this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion purchase of Crinetics, and more.
In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies,
OpenAI’s healthcare push, Vertex’s $10 billion purchase of Crinetics, and more.Get AI news in your inbox
Daily digest of what matters in AI.